Siemens Seeks Bulk License for Ecgonine Production
Published Date: 2/13/2026
Notice
Summary
Siemens Healthcare Diagnostics, Inc. wants to become a big-time maker of a controlled substance called Ecgonine, used to make special DEA-exempt products. People who already make or use this drug can share their thoughts or ask for a hearing by April 14, 2026. This move could shake up the market but doesn’t mention any costs or fees right now.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in